A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis

Osteoarthritis Clinical Trial

— MINDFULNESS_OA  

Official title:

A Randomized Controlled Trial of a Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03644615
• Other study ID #: 7534
• Status: Completed
• Phase: N/A
• Start date: September 5, 2018
• Est. completion date: September 4, 2019

Study information

• Verified date: June 2022
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Symptomatic osteoarthritis (OA) is the most common joint disease and the leading cause of disability in industrialized countries. Therapeutic approaches to prevent the development and progression of osteoarthritis are disappointing and very limited. New therapeutic alternatives seem essential to better manage his daily life. Non-drug approaches, including psycho-corporal approaches are increasingly used in the management of chronic pain. Mindfulness is a technique of attention training, which is to focus one's attention on the present moment and to examine the sensations that come to mind, how they appear, how they last time, and how they disappear. Regarding rheumatological pathologies, a Mindfulness Program (MBSR) has shown its effectiveness in chronic pain; and in particular in osteo-articular localization, such as chronic low back pain. A recent study found a correlation between a pre-disposition to mindfulness and less pain and / or better quality of life in patients with knee osteoarthritis. However, to the knowledge of investigator, no study has evaluated the effectiveness of an intervention based on a mindfulness training program as a therapeutic alternative in osteoarthritis of the knee or hip. The goal of investigator is to evaluate, using a randomized, controlled study, the effect of a mindfulness program (according to the MBSR protocol) on pain, function, psychological state and quality of life patients with knee or hip osteoarthritis

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: September 4, 2019
• Est. primary completion date: March 4, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 75 Years

Eligibility

Inclusion Criteria:

• Osteoarthritis of the knee or hip (Kellgren and Lawrence X-ray stage = 2)
• Mean pain VAS on at least one reference joint (knee or hip)> 40 mm during the last week
• Stable treatment with analgesics for at least a week

Exclusion Criteria:

• Corticosteroids (oral or injectable) in the month prior to inclusion
• Intra-articular injection of hyaluronic acid in the last 3 months prior to inclusion
• Inflammatory rheumatic disease (rheumatoid arthritis, spondyloarthritis, CCPD)
• Current depressive episode
• Psychotic disorders
• Usual practice of a relaxation method (mindfulness, yoga, sophrology ...)
• Major protected by law (guardianship, curatorship or under the safeguard of justice)
• Subject in a period of exclusion relative to another protocol or for which the annual amount maximum compensation of € 4500 has been reached.
• Subject participating in another research protocol
• Subject not affiliated to a social security
• Pregnant woman, parturient or nursing, patient unable to give her major consent protected, vulnerable persons (Articles L.1121-6, L.1121-7, L.1211-8, L.1211-9)
• Subject deprived of liberty by judicial or administrative decision

Related Conditions & MeSH terms

• MBSR
• Mindfulness
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Other:
• Mindfluness and usual care
Intervention based on a mindfulness training program as a therapeutic alternative in osteoarthritis of the knee or hip. Mindfulness is a technique of attention training, which is to focus one's attention on the present moment and to examine the sensations that come to mind, how they appear, how they last time, and how they disappear.
• Usual care
No intervention on the patients

Locations

Country	Name	City	State
France	Rhumatology Department - CHU Montpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

References & Publications (1)

Marais C, Song Y, Ferreira R, Aounti S, Duflos C, Baptista G, Pers YM. Evaluation of mindfulness based stress reduction in symptomatic knee or hip osteoarthritis patients: a pilot randomized controlled trial. BMC Rheumatol. 2022 May 30;6(1):46. doi: 10.11 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the efficacy of a mindfulness program as a treatment for hip or knee osteoarthritis on the WOMAC pain score.	Improvement in WOMAC pain before and after the program in the MBSR group compared to control group. The WOMAC is a validated index in the assessment of lower extremity osteoarthritis, by the system of rating the answers to questions by a visual analogue scale from 0 to 100 mm. It is possible to calculate the scores in each domain (pain, stiffness and function) or for the whole WOMAC. This is a self-administered questionnaire completed by the patient.	6 months
Secondary	Changes in pain scores (VAS/100) between initiation visit and 3 months	EVA pain (visual analogue scale over 100 mm): one-dimensional measurement of the intensity of pain. EVA pain is a continuous scale consisting of a horizontal line from 0 (no pain) to 100 mm (maximum pain)	3 months
Secondary	Changes in pain scores (VAS/100) between initiation visit and 6 months	EVA pain (visual analogue scale over 100 mm): one-dimensional measurement of the intensity of pain. EVA pain is a continuous scale consisting of a horizontal line from 0 (no pain) to 100 mm (maximum pain)	6 months
Secondary	Changes in WOMAC questionnaire (total, pain, function and stiffness) between initiation visit and 3 months	The WOMAC is a validated index in the assessment of lower extremity osteoarthritis, by the system of rating the answers to questions by a visual analogue scale from 0 to 100 mm. It is possible to calculate the scores in each domain (pain, stiffness and function) or for the whole WOMAC. This is a self-administered questionnaire completed by the patient.	3 months
Secondary	Changes in WOMAC questionnaire (total, pain, function and stiffness) between initiation visit and 6 months	The WOMAC is a validated index in the assessment of lower extremity osteoarthritis, by the system of rating the answers to questions by a visual analogue scale from 0 to 100 mm. It is possible to calculate the scores in each domain (pain, stiffness and function) or for the whole WOMAC. This is a self-administered questionnaire completed by the patient.	6 months
Secondary	Changes in OARSI-OMERACT response criteria between initiation visit and 3 months	The responder rate is defined by an improvement of 20%, with an absolute variation = 10mm, on 2 of the following 3 measures: WOMAC pain, WOMAC function and / or overall assessment of disease activity by the patient.; The overall evaluation of the patient's disease activity is performed on a 100 mm horizontal visual analogue scale (0 = inactive disease, 100 = highly active disease). It is used for the global assessment of the activity of the disease by the patient.	3 months
Secondary	Changes in OARSI-OMERACT response criteria between initiation visit and 6 months	The responder rate is defined by an improvement of 20%, with an absolute variation = 10mm, on 2 of the following 3 measures: WOMAC pain, WOMAC function and / or overall assessment of disease activity by the patient.; The overall evaluation of the patient's disease activity is performed on a 100 mm horizontal visual analogue scale (0 = inactive disease, 100 = highly active disease). It is used for the global assessment of the activity of the disease by the patient.	6 months
Secondary	Changes in SF-36 score between initiation visit and 3 months	The SF-36 includes 36 items divided into 8 dimensions (physical functioning, limitations of functions related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, limitations of functions related to mental health, physical health) to which were added 4 items examining the cognitive functioning, from the "Medical Outcomes Study". This questionnaire was supplemented by questions aimed at clarifying the socio-demographic profile of the participants as well as the use of care services.	3 months
Secondary	Changes in SF-36 score between initiation visit and 6 months	The SF-36 includes 36 items divided into 8 dimensions (physical functioning, limitations of functions related to physical health, physical pain, general health, vitality [energy / fatigue], functioning or social well-being, limitations of functions related to mental health, physical health) to which were added 4 items examining the cognitive functioning, from the "Medical Outcomes Study". This questionnaire was supplemented by questions aimed at clarifying the socio-demographic profile of the participants as well as the use of care services.	6 months
Secondary	Changes in HAD score between initiation and 3 months	The Hospital Anxiety and Depression (HAD) questionnaire assesses the psychological impact of the patient. It consists of 14 questions with 4 possible answers. This score makes it possible to differentiate a level of anxiety and a level of depression according to the answers. Each sub-scale varies from 0 to 21	3 months
Secondary	Changes in HAD score between initiation and 6 months	The Hospital Anxiety and Depression (HAD) questionnaire assesses the psychological impact of the patient. It consists of 14 questions with 4 possible answers. This score makes it possible to differentiate a level of anxiety and a level of depression according to the answers. Each sub-scale varies from 0 to 21	6 months

External Links

•   open access